Skip to main content

CVS Nighttime Childrens

NDC 51316-752 · CVS PHARMACY

Generic nameChlorpheniramine maleate and Dextromethorphan Hydrobromide
Dosage formSOLUTION
RouteORAL
Active ingredient(s)CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE
Strength2; 15 mg/15mL; mg/15mL
Pharmacologic classHistamine H1 Receptor Antagonists [MoA], Histamine-1 Receptor Antagonist [EPC], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryOTC MONOGRAPH DRUG

Packages

51316-752-08 — 236 mL in 1 BOTTLE, PLASTIC (51316-752-08)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

51316-671 — dextromethorphan hydrobromide, guaifenesin, 51316-676 — acetaminophen, dextromethorphan hydrobromide, 51316-681 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 51316-692 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 51316-727 — ACETAMINOHPEN, DEXTROMETHORPHAN HBr, GUAIFENESIN PHENYLEPHRINE HCL, 51316-731 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, phenylephrine hydrochloride, 51316-738 — Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, 51316-740 — Dextromethorphan HBr, Guaifenesin, 51316-744 — dextromethorphan hydrobromide and guaifenesin, 51316-745 — chlorpheniramine maleate, dextrometrorphan HBr, 51316-775 — Dextromethorphan HBr, Guaifenesin, 51316-778 — Dextromethorphan Hydrobromide, 51316-791 — Dextromethorphan Hydrobromide, Doxylamine Succinate, 51316-803 — Acetaminophen, Dextromethorphan HBr, 51316-808 — Dextromethorphan HBr, Guaifenesin, 51316-815 — Dextromethorphan HBr, guaifenesin, Phenylephrine HCl, 51316-826 — Dextromethorphan Hydrobromide, Guaifenesin, 51316-830 — Dextromethorphan hydrobromide, Guaifenesin, 51316-858 — dextromethorphan hydrobromide, guaifenesin, 51316-877 — Dextromethorphan hydrobromide, +2124 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels